Shih‐Ping Hsu

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients

Shih‐Ping Hsu · Nephrology Dialysis Transplantation · 2004 · 173 citations · Full text

Sleep Disturbance in Chronic Hemodialysis Patients: The Impact of Depression and Anemia

Mei‐Fen Pai, Shih‐Ping Hsu, Shao‐Yu Yang et al. · Renal Failure · 2007 · 125 citations

Interleukin-31 is associated with uremic pruritus in patients receiving hemodialysis

Mei‐Ju Ko, Yu‐Sen Peng, Hung‐Yuan Chen et al. · Journal of the American Academy of Dermatology · 2014 · 116 citations

Inflammation, Glomerulonephritis, Hemodialysis +11